New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

Bausch to Dish Out $300M in Pay-to-Delay Settlement

The lawsuit claimed the company paid off generic rivals, allowing the company to increase prices 800%.

A recent FiercePharma article discussed the massive settlement Bausch Health will pay for actions aimed at protecting their diabetes medication Glumetza. The Canadian drugmaker will pay $300 million for a 2019 lawsuit that claims the company paid off generic rivals so that the company could increase prices 800% for their type 2 diabetes drug. The class action lawsuit was driven by direct purchasers of the medication, and was set to go to trial in October.

Discover Our Content Hub
Access Packaging World's free educational content library!
Read More
Discover Our Content Hub
How AI is reshaping CPG manufacturing operations
Today’s CPG companies are faced with mounting challenges in their manufacturing operations. You have the data that could help you, but can you turn that data into knowledge? See how artificial intelligence can help. Learn what’s working for Pfizer, Post, and Smithfield.
Read More
How AI is reshaping CPG manufacturing operations